These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 17446160

  • 1. [Clinical trials of new therapeutic pharmacology for sickle cell disease].
    Brugnara C, de Franceschi L.
    Sante; 2006; 16(4):263-8. PubMed ID: 17446160
    [Abstract] [Full Text] [Related]

  • 2. Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
    McNaughton-Smith GA, Burns JF, Stocker JW, Rigdon GC, Creech C, Arrington S, Shelton T, de Franceschi L.
    J Med Chem; 2008 Feb 28; 51(4):976-82. PubMed ID: 18232633
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic strategies for prevention of sickle cell dehydration.
    Brugnara C.
    Blood Cells Mol Dis; 2001 Feb 28; 27(1):71-80. PubMed ID: 11358364
    [Abstract] [Full Text] [Related]

  • 4. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
    Ataga KI, Reid M, Ballas SK, Yasin Z, Bigelow C, James LS, Smith WR, Galacteros F, Kutlar A, Hull JH, Stocker JW, ICA-17043-10 Study Investigators.
    Br J Haematol; 2011 Apr 28; 153(1):92-104. PubMed ID: 21323872
    [Abstract] [Full Text] [Related]

  • 5. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH.
    Trends Pharmacol Sci; 2006 Apr 28; 27(4):204-10. PubMed ID: 16530854
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.
    Brugnara C, de Franceschi L, Alper SL.
    J Clin Invest; 1993 Jul 28; 92(1):520-6. PubMed ID: 8326017
    [Abstract] [Full Text] [Related]

  • 7. Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration.
    Brugnara C.
    J Pediatr Hematol Oncol; 2003 Dec 28; 25(12):927-33. PubMed ID: 14663274
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined genetic disruption of K-Cl cotransporters and Gardos channel KCNN4 rescues erythrocyte dehydration in the SAD mouse model of sickle cell disease.
    Shmukler BE, Rivera A, Bhargava P, Nishimura K, Hsu A, Kim EH, Trudel M, Rust MB, Hubner CA, Brugnara C, Alper SL.
    Blood Cells Mol Dis; 2019 Nov 28; 79():102346. PubMed ID: 31352162
    [Abstract] [Full Text] [Related]

  • 10. Thrombosis and sickle cell disease.
    De Franceschi L, Cappellini MD, Olivieri O.
    Semin Thromb Hemost; 2011 Apr 28; 37(3):226-36. PubMed ID: 21455857
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of red cell dehydration: a possible new treatment for sickle cell disease.
    Mueller BU, Brugnara C.
    Pediatr Pathol Mol Med; 2001 Apr 28; 20(1):15-25. PubMed ID: 12673842
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Established and experimental treatments for sickle cell disease.
    De Franceschi L, Corrocher R.
    Haematologica; 2004 Mar 28; 89(3):348-56. PubMed ID: 15020275
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
    De Franceschi L, Saadane N, Trudel M, Alper SL, Brugnara C, Beuzard Y.
    J Clin Invest; 1994 Apr 28; 93(4):1670-6. PubMed ID: 7512989
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sickle cell dehydration: Pathophysiology and therapeutic applications.
    Brugnara C.
    Clin Hemorheol Microcirc; 2018 Apr 28; 68(2-3):187-204. PubMed ID: 29614632
    [Abstract] [Full Text] [Related]

  • 20. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease.
    Brugnara C.
    Curr Opin Hematol; 1995 Mar 28; 2(2):132-8. PubMed ID: 9371983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.